Last Updated on June 22, 2023

Current Cancer Therapy Reviews- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Bentham Science Publishers B.V.

Abbreviation: Curr. Cancer Ther. Rev.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

0.54

SJR

 0.147

h-Index

 17

Rank

 22099

Important Details

Title Current Cancer Therapy Reviews
Standard Abbreviation Curr. Cancer Ther. Rev.
Type of Publication Journal
Discipline Cancer Research (Q4); Molecular Medicine (Q4); Oncology (Q4)
Impact Score 0.54
SCImago Journal Rank (SJR) 0.147
h-index 17
Overall Rank 22099
Publisher Name Bentham Science Publishers B.V.
Publication Country United Arab Emirates
International Standard Serial Number (ISSN) 15733947
Coverage and History 2006-2022
Best Quartile Q4
Total Citations Received
(Last 3 Year)
43

About Current Cancer Therapy Reviews


Current Cancer Therapy Reviews is a journal published by Bentham Science Publishers B.V.. This journal covers the area[s] related to Cancer Research, Molecular Medicine, Oncology, etc. The coverage history of this journal is as follows: 2006-2022. The rank of this journal is 22099. This journal's impact score, h-index, and SJR are 0.54, 17, and 0.147, respectively. The ISSN of this journal is/are as follows: 15733947.

The best quartile of Current Cancer Therapy Reviews is Q4. This journal has received a total of 43 citations during the last three years (Preceding 2022).


Current Cancer Therapy Reviews Impact Score 2022-2023


The latest impact score (IS) of the Current Cancer Therapy Reviews is 0.54. It is computed in the year 2023 as per its definition and based on Scopus data. 0.54

It is increased by a factor of around 0.17, and the percentage change is 45.95% compared to the preceding year 2021, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Current Cancer Therapy Reviews Impact Score 2023


Impact Score 2022 of Current Cancer Therapy Reviews is 0.54. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Current Cancer Therapy Reviews. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.54
2021 0.37
2020 0.25
2019 0.35
2018 0.22
2017 0.06
2016 0.25
2015 0.33
2014 0.31

Current Cancer Therapy Reviews h-index


  Table Setting

The h-index of Current Cancer Therapy Reviews is 17. By definition of the h-index, this journal has at least 17 published articles with more than 17 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Current Cancer Therapy Reviews ISSN


The International Standard Serial Number (ISSN) of Current Cancer Therapy Reviews is/are as follows: 15733947.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Current Cancer Therapy Reviews Ranking and SCImago Journal Rank (SJR)


The Current Cancer Therapy Reviews is ranked 22099 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.147.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Current Cancer Therapy Reviews Publisher


Table Setting

The publisher of Current Cancer Therapy Reviews is Bentham Science Publishers B.V.. The publishing house of this journal is located in the United Arab Emirates. Its coverage history is as follows: 2006-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Current Cancer Therapy Reviews is Curr. Cancer Ther. Rev.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Curr. Cancer Ther. Rev.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Current Cancer Therapy Reviews


If your area of research or discipline is related to Cancer Research, Molecular Medicine, Oncology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Current Cancer Therapy Reviews?

The latest impact score of Current Cancer Therapy Reviews is 0.54. It is computed in the year 2023.


What is the h-index of Current Cancer Therapy Reviews?

The latest h-index of Current Cancer Therapy Reviews is 17. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Current Cancer Therapy Reviews?

The latest SCImago Journal Rank (SJR) of Current Cancer Therapy Reviews is 0.147. It is calculated in the year 2023.


What is the ranking of Current Cancer Therapy Reviews?

The latest ranking of Current Cancer Therapy Reviews is 22099. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Current Cancer Therapy Reviews?

Current Cancer Therapy Reviews is published by Bentham Science Publishers B.V.. The publication country of this journal is United Arab Emirates.


What is the abbreviation of Current Cancer Therapy Reviews?

This standard abbreviation of Current Cancer Therapy Reviews is Curr. Cancer Ther. Rev..


Is "Current Cancer Therapy Reviews" a Journal, Conference or Book Series?

Current Cancer Therapy Reviews is a journal published by Bentham Science Publishers B.V..


What is the scope of Current Cancer Therapy Reviews?

The scope of Current Cancer Therapy Reviews is as follows:

  • Cancer Research
  • Molecular Medicine
  • Oncology

For detailed scope of Current Cancer Therapy Reviews, check the official website of this journal.


What is the ISSN of Current Cancer Therapy Reviews?

The International Standard Serial Number (ISSN) of Current Cancer Therapy Reviews is/are as follows: 15733947.


What is the best quartile for Current Cancer Therapy Reviews?

The best quartile for Current Cancer Therapy Reviews is Q4.


What is the coverage history of Current Cancer Therapy Reviews?

The coverage history of Current Cancer Therapy Reviews is as follows 2006-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Zeitschrift fur Germanistische Linguistik Journal De Gruyter Mouton 22945 15 0.19
Analysis in Theory and Applications Journal Springer Netherlands 19346 11 0.00
SPE Production and Operations Symposium, Proceedings Conference And Proceedings 15907 21 0.00
Milan Journal of Mathematics Journal Birkhauser Verlag Basel 3120 28 1.79
Journal of Business Finance and Accounting Journal Wiley-Blackwell Publishing Ltd 3221 84 3.68
Discourse Journal Routledge 6621 59 2.11
Child and Family Social Work Journal Wiley-Blackwell Publishing Ltd 8628 67 2.20
European Surgery - Acta Chirurgica Austriaca Journal Springer Medizin 16873 23 0.58
Sapporo Medical Journal Journal Cancer Research Institute, Sapporo Medical University 20468 3 0.00
Poljoprivreda Journal Faculty of Agriculture in Osijek 20724 14 0.67

Check complete list




Current Cancer Therapy Reviews Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 0.54
2021 0.37
2020 0.25
2019 0.35
2018 0.22
2017 0.06
2016 0.25
2015 0.33
2014 0.31



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Cancer
Cell Press | United States

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Biomarker Research
BioMed Central Ltd. | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All